Abstract:Yanhua Fu, 1 Yuanyuan Xiao, 2 Tianji Gao, 1 Junxiu Zhang, 3 Tianjiao Wang 1 1 Department of Rheumatology, Baoding Hospital of Beijing Children's Hospital, Baoding, 071000, People's Republic of China; 2 Department of Dermatology, National Center for Children's Health (Beijing) Children's Hospital Affiliated to Capital Medical University, Beijing, 100045, People's Republic of China; 3 Department of Dermatology, Baoding Hospital of Beijing Children's Hospital, Baoding, 071000, People's Republic of China Correspondence: Yuanyuan Xiao, Department of Dermatology, National Center for Children's Health (Beijing) Children's Hospital Affiliated to Capital Medical University, No. 56 of Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China, Tel +86 10 59612345, Email Toxic epidermal necrolysis (TEN) is a type of drug eruption in dermatology emergencies that is rare in clinical practice but has a high mortality rate. The main causes are drug and viral infections. Unfortunately, no expert consensus on treating this disease exists, and a standard therapy is absent. Up to now, glucocorticoids combined with gamma globulin are commonly used in clinical practice, but their efficacy is highly controversial. This study reports on a 7-year-old girl with TEN who did not respond to traditional therapy, such as methylprednisolone combined with gamma globulin, but was finally cured with an additional low-dose etanercept. The results showed that etanercept therapy in paediatric TEN is safe, reliable and worth recommending. Keywords: child toxic epidermal necrolysis, etanercept, glucocorticoids, gamma globulin Toxic epidermal necrolysis (TEN) is a potentially life-threatening delayed hypersensitivity reaction primarily triggered by medications. It exhibits rapid onset and severe progression, with a 30–35% mortality rate. 1 Toxic epidermal necrolysis can affect individuals of all ages and is linked to various medications and infections. Causative medications for TEN include antibiotics, anticonvulsants, sulphonamides and allopurinol. The typical clinical manifestations of TEN are widespread erythema, blistering and severe epidermal necrosis and detachment, sometimes leading to multi-organ involvement. Despite the growing understanding of the condition, consensus regarding the optimal treatment regimen for TEN remains elusive. Clinically, conventional treatments such as cyclophosphamide, cyclosporine and glucocorticoid (GC) therapy are often employed but are accompanied by significant side effects and an increased risk of infection. 2,3 Although previous literature has discussed using biological agents in treating adult patients with TEN, scant information exists regarding paediatric patients. 4 To date, only 4 children with toxic epidermal necrolysis have been treated with infliximab and 2 with etanercept. Andrea et al 5 reported an 8-year-old boy who was diagnosed with TEN induced by levetiracetam. He was first treated with methylprednisolone 1.5mg/kg/d and intravenous immunoglobulin 1g/kg/d for 5 consecutive days. However, significant progression and mucosal lesions were observed 2 days later, followed by etanercept at a dose of 0.8mg/kg (25mg), which stopped blistering within 24 hours after the use of etanercept, and the mucosal lesions were alleviated. Gavigan et al 6 reported an 11-year-old girl whose symptoms were significantly relieved after receiving methylprednisolone for 4 days 30mg/kg/d, cyclosporine 5mg/kg/d for 3 days, and 2 doses of etanercept 25mg every 24 hours. Although it has been reported that etanercept is effective in the treatment of TEN, there are still few reports about etanercept in the treatment of TEN in children. Therefore, it is necessary to explore the treatment of etanercept in children with TEN and summarize the clinical experience. In our department, we encountered a paediatric patient with TEN and effectively treated her using a combination therapy of etanercept (Yisaipu), GCs, and intravenous immunoglobulin (IVIG). Given the favourable outcomes, a detailed account of this case is provided in this report. A 7-year-old girl was admitted with the chief complaints of fever, rash and lip swelling for 2 days. Two days before admission, the patient developed an unprovoked fever, with the highest recorded temperature reaching 39.6°C. Initial fever management with ibuprofen failed to alleviate the symptoms. The patient did not experience chills or seizures. Subsequently, erythematous patchy skin rashes appeared on her face and ears, gradually spreading throughout her body. Concurrently, the patient developed blisters on her limbs and trunk and complained of itching on her hands and feet. Pronounced lip swelling was also noted (Figure 1A). The patient -Abstract Truncated-

Toxic Epidermal Necrolysis Induced by Ritodrine in Pregnancy: A Case Report

Ritodrine-induced rhabdomyolysis and psychiatric symptoms: a case report and literature review

Clinical Analysis of Tocolysis with Ritodrine Hydrochloride or Atosibanin Treatment of Threatened Preterm Labour

Adverse Reactions of Ritodrine Hydrochloride in Prevention of Premature Birth and the Prophylactico-Therapeutic Measures

Nursing of Ritodrine Hydrochloride Treatment 122 Cases of Threatened Premature Delivery

Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant women

A singleton pregnancy with placental chorioangioma and hydrops fetalis complicated with mirror syndrome and ritodrine-induced side effects: a case report

Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan

Treatment of preterm labor with ritodrine]

Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial.

Study on the Effects of CRH, E2 and IL-10 of Patients with Threatened Premature Labor by Ritodrine Hydrochloride

Toxic Epidermal Necrolysis in a Child

Acquired methemoglobinemia in a third trimester puerpera and her premature infant with sodium nitrite poisoning: A case report

Significant Effect of Ritodrine Hydrochloride Combined with Magnesium Sulfate for Treatment of Patients with Premature Rupture of Membranes

Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated with Clinically Amyopathic Dermatomyositis in a Post-partum Woman.

Rebound hyperkalemia after cessation of ritodrine in a parturient undergoing cesarean section

Etanercept Combined with Glucocorticoid and Gamma Globulin for Treating Children with Toxic Epidermal Necrolysis: A Case Report

Clinical Efficacy and Maternal and Infant Outcomes of Ritodrine Hydrochloride and Magnesium Sulfate in the Treatment of Placenta Previa

Synergic interaction between ritodrine and magnesium sulfate on the occurrence of critical neonatal hyperkalemia: A Japanese nationwide retrospective cohort study

Preterm Labor Using Tocolysis as a Possible Risk Factor for Postpartum Depression: A 14-Year Population-Based Study in Taiwan

Toxic Epidermal Necrolysis Superimposed on Severe Drug Rash With Eosinophilia and Systemic Symptoms Complicated by Fatal Hemophagocytic Lymphohistiocytosis: A Case Report